Patients' Attitudes Towards Open-Label Placebo Implementation Into Clinical Practice

CompletedOBSERVATIONAL
Enrollment

6

Participants

Timeline

Start Date

December 16, 2021

Primary Completion Date

November 10, 2022

Study Completion Date

November 10, 2022

Conditions
Open-label Placebos
Interventions
OTHER

focus group discussions (FGD)

FGD to explore patients' attitudes/ concerns towards OLP implementation into clinical practice by means of assessment of qualitative information: 1) Patients' attitudes towards clinical usage of OLPs 2) Personal acceptance of OLP intervention 3) Perceived ideas, concerns regarding OLP implementation. Core questions: 1) Attitudes: After all that I told you about placebos, i.e. that there is a concept that patients are openly elucidated that they receive placebos: What does this elicit in you/What is your opinion on this? How do you like the idea? 2) Context of Acceptance: Under which conditions would you personally take placebos knowing that they are placebos? 3) Concerns: Why would you not take openly administered placebos? 4) Ideas for clinical implication: How could an open placebo intervention look like in the hospital? Where could it be possible to receive placebos and how could a placebo intervention in the best manner take place? What would be important from your point of view?

Trial Locations (1)

4055

University of Basel, Faculty of Psychology, Division of Clinical Psychology and Psychotherapy, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT05166213 - Patients' Attitudes Towards Open-Label Placebo Implementation Into Clinical Practice | Biotech Hunter | Biotech Hunter